Navigation Links
Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
Date:9/6/2007

KNOXVILLE, TN--Provectus Pharmaceuticals, Inc. (OTCBB:PVCT) announced that it has obtained approval to begin Phase 2 clinical testing of Provecta for the treatment of Stage III and IV metastatic melanoma, the most aggressive and deadly form of skin cancer. The multi-center study is designed to evaluate efficacy of Provecta in a total of 80 subjects.

In the study, Provecta will be injected into up to 20 tumors in each subject. Additional treatment with Provecta may be made 8 to 16 weeks after this initial injection, if deemed necessary by the investigator. Response will be observed for 1 year, during which data will be gathered for assessment of objective response rate, progression free survival, quality of life and safety. In addition, CT imaging will be used to monitor changes in any internal (e.g., visceral or brain) metastases. The lead site for the study is the Sydney Melanoma Unit in Australia. Over the next several months the study will expand to include sites in a number of major population centers in Australia as well as several sites in the U.S.

Craig Dees, Ph.D., Chief Executive Officer of Provectus, stated, Building on the results from our Phase 1 study, which looked at safety and objective response upon injection of Provecta into more than 100 metastatic melanoma tumors in 20 subjects, we have put forth an aggressive clinical plan to drive toward approval of the drug for use in this devastating disease. Dees continued, Preliminary analysis of data from Phase 1 shows that Provecta, which has received orphan drug designation in the U.S., was well tolerated with generally mild side effects. Having completed final follow-up for the last of these subjects, we expect to announce summary response data in the near future.


'/>"/>
Contact: Janet Vasquez
janet@investorrelationsgroup.com
212-825-3210
Provectus Pharmaceuticals
Source:Eurekalert

Page: 1

Related medicine news :

1. Risk of heart disease begins in teens
2. Cancer Begins With Epigenetic Changes: Study
3. Learning About Healthy Diet Choices Begins At Schools
4. China Begins Human Trials For HIV/AIDS Drug
5. Administration of Fish Drug for Asthma Patients Begins in Andhra
6. Harvard Begins Controversial Human Stem Cell Cloning Project
7. Writing on the Wall - Lead Poisoning Begins at Home?Paints Could Be Toxic!
8. The Blessing of Good Mental Health Begins with Breast Milk, Says a Study
9. India sounds bird flu alert as migration season begins
10. Keys to Good Health in Old Age Begins in Midlife
11. Cancer Prevention Begins During Pregnancy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 2014 Following the death of an 18-year-old ... FDA issued a warning on powdered caffeine products. ... substance that is readily available to consumers, despite the fact ... senior Logan Stiner died from an overdose of caffeine powder. ... the FDA to issue a safety advisory for caffeine powders. ...
(Date:8/28/2014)... 28, 2014 Catalent Pharma Solutions, ... and development solutions for drugs, biologics and consumer ... Director Clinical Supply Services, and Chris Greco, Manager, ... Sourcing Strategies for Active Control Clinical Trials” at ... takes place on the 9th – 10th September, ...
(Date:8/28/2014)... 2014) A subset of patients with stage III ... irinotecan-based therapy, according to a new study in ... of the American Gastroenterological Association. , When added to ... adjuvant irinotecan therapy improved overall survival rates for patients ... seen in about 10 to 20 percent of colorectal ...
(Date:8/28/2014)... scientists are working out how to safely increase the ... offering improved local control and survival. , Standard treatment ... combination of radiotherapy and chemotherapy. Traditionally this is planned ... not always be enough to stop tumour growth. , ... cancerous tissue varies between patients and depends on the ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 AmeriPride Services, ... America, today announced the launch of its new Customer ... AmeriPride even easier and more convenient for customers. The ... online and better communicate with the company. , Features ... Access, download and pay bills ...
Breaking Medicine News(10 mins):Health News:FDA Issues Safety Advisory for Caffeine Powders 2Health News:Critical Path Sourcing Strategies for Global Clinical Trials Presented by Catalent Experts at US Clinical Trials Supply Conference 2Health News:Drug shows promise for subset of stage III colon cancer patients 2Health News:Research demonstrates potential method to better control lung cancer using radiotherapy 2Health News:AmeriPride Services Launches New Customer Portal 2Health News:AmeriPride Services Launches New Customer Portal 3
... researchers say , SUNDAY, Nov. 18 (HealthDay News) -- ... suggests. , A U.S. team found that talking to ... and test scores. , They found that "socializing was ... exercise in boosting memory and intellectual performance," lead author ...
... costs and prepare ... covers of hospital costs and, efficiencies using more refined performance metrics ... ... A new benchmarking study was,launched today to measure the cost and efficiencies of ...
... it from spreading, expert says , , SATURDAY, Nov. 17 (HealthDay News) ... hit by the flu bug this year, but some simple precautions ... said. , The flu shot is the most effective method of ... officer at Brigham and Women,s Hospital in Boston. It,s important to ...
... Nancy Pelosi,will join Congressmen Ciro D. Rodriguez, Charlie ... the State Children,s Health,Insurance Program (SCHIP) bill that ... WHO: Speaker Nancy Pelosi Congressman Ciro D. ... Congressman Henry Cuellar (TX-28), WHAT: Rally for ...
... Nov. 16 Angel Flight West,(AFW) awarded The Distinguished ... Dan Telfair at AFW,s 24th Anniversary Awards and on ... awards event. Telfair,completed 56 missions over the past year. ... non-emergency health care problems require that they travel,to and ...
... Nov. 16 Nothing says,"Thanksgiving" like football, family and ... But no matter what,s included in a,Thanksgiving spread, one ... the American Society for Surgery of the Hand cautions,carvers ... not their own hands., Every year during Thanksgiving, ...
Cached Medicine News:Health News:Talking With Others May Make You Smarter 2Health News:Global Health Support Service Benchmark Study to Combat Growing Healthcare Costs and Prepare for Likely Health Care Reforms 2Health News:Angel Flight West Recognizes New Mexico Pilots and Receives Grant to Improve Access to Health Care 2Health News:Holiday Hand Safety 101: Hand Surgeons Offer Tips for a Safe Carving Season 2
(Date:8/28/2014)... Aug. 28, 2014  A decline in revenues ... are adding pressure to pharmaceutical, biotechnology and medical ... continue to shrink and approval processes and postapproval ... companies to look for additional support and expertise ... keeping approved products on the market.  ...
(Date:8/28/2014)... VIEJO , Californie, 28 août ... a annoncé aujourd,hui le début des ... d,une étude  d,exemption des dispositifs expérimentaux ... destinée à évaluer l,innocuité et l,efficacité ... (« WEB »). Le docteur Adam Arthur ...
(Date:8/28/2014)... , Aug. 28, 2014  Celsion Corporation (NASDAQ: ... company, today announced that Michael H. Tardugno , ... at the Rodman & Renshaw 16th Annual Healthcare Conference ... a.m. Eastern Time. The conference is being held at ... A copy of the presentation will be available on ...
Breaking Medicine Technology:4 Key Factors to Consider When Choosing an Effective Regulatory Outsourcing Partner 24 Key Factors to Consider When Choosing an Effective Regulatory Outsourcing Partner 34 Key Factors to Consider When Choosing an Effective Regulatory Outsourcing Partner 4Sequent Medical annonce le démarrage d'une étude IDE pour le système WEB d'embolisation des anévrismes 2Sequent Medical annonce le démarrage d'une étude IDE pour le système WEB d'embolisation des anévrismes 3Sequent Medical annonce le démarrage d'une étude IDE pour le système WEB d'embolisation des anévrismes 4Celsion to Present at the Rodman & Renshaw 16th Annual Healthcare Conference 2
... Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing ... chief operations officer, will present at ThinkEquity,s Second Annual ... a.m. ET. The conference will be held at The ... About AbaxisAbaxis develops, manufactures, markets and sells portable blood ...
... presented this week at the International Federation of Clinical ... lower diagnostic threshold for troponin improves clinical outcomes and ...  Troponin is a protein found inside of heart cells ... or reduced blood supply.   Cardiac troponin ...
Cached Medicine Technology:Study Shows Improved Patient Management and Outcome Using Abbott's Sensitive Troponin Assay 2Study Shows Improved Patient Management and Outcome Using Abbott's Sensitive Troponin Assay 3Study Shows Improved Patient Management and Outcome Using Abbott's Sensitive Troponin Assay 4
For Atrial Mapping. Biosense Webster offers a complete line of specialty 20-pole catheters. The CRISTA CATH 20-pole deflectable catheter is designed for positioning along the crista terminals....
... Inquiry H Steerable Catheter. Steerable ... variety of designs and a ... stability. 10 to 24 electrodes, ... inactive and active tip electrodes, ...
Sophisticated DecaPolar Catheters provide enhanced recording and mapping quality....
... Torqr Quadripolar Braided Shaft ... The Medtronic CardioRhythm Torqr ... use in diagnostic electrophysiologic ... designed for recording intracardiac ...
Medicine Products: